Streetbeat News

Analyst Ratings

EVBN

Piper Sandler analyst Alexander Twerdahl downgraded Evans Bancorp (EVBN) from Overweight to Neutral and set a price target of $32.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:55 pm

EW

Wells Fargo analyst Larry Biegelsen upgraded Edwards Lifesciences (NYSE:EW) from Equal-Weight to Overweight and set a $94 price target.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:49 pm

NXT

Goldman Sachs analyst Brian Lee has maintained a Buy rating on NEXTracker (NASDAQ:NXT) and increased the price target from $62 to $70.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:48 pm

MCHP

Goldman Sachs analyst Toshiya Hari has maintained a Neutral rating on Microchip Technology (NASDAQ:MCHP) and lowered the price target from $87 to $77.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:47 pm

CELH

Maxim Group analyst Anthony Vendetti upgraded Celsius Holdings (NASDAQ:CELH) from Hold to Buy and set a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:45 pm

AMZN

RBC Capital analyst Brad Erickson maintains an Outperform rating on Amazon.com (NASDAQ:AMZN) and raises the price target from $180 to $215.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:42 pm

ATKR

RBC Capital analyst Deane Dray has reiterated an Outperform rating on Atkore (NYSE:ATKR) and maintained a price target of $187.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:36 pm

META

Goldman Sachs analyst Eric Sheridan has maintained a Buy rating on Meta Platforms (NASDAQ:META) and increased the price target from $414 to $500.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:35 pm

AMZN

CI

CLX

DECK

META

Clorox reported better-than-expected Q2 financial results and raised FY24 EPS guidance, leading to a 4.6% stock increase. Other stocks like Tyra Biosciences, Meta Platforms, and Deckers Outdoor also saw significant gains due to positive financial news or analyst upgrades. Companies like Amazon and Cigna reported strong results and provided optimistic future guidance, contributing to their stock's upward movement.

Portfolio Pulse from Avi Kapoor

February 02, 2024 | 3:35 pm

TEAM

Goldman Sachs analyst Kash Rangan has maintained a Neutral rating on Atlassian (NASDAQ:TEAM) and raised the price target from $188 to $215.

Portfolio Pulse from Benzinga Newsdesk

February 02, 2024 | 3:34 pm